The increasing number of sequenced genes that can be used to develop tests for inherited conditions has stimulated an increasing number of genetics-based narratives by journalists, novelists, playwrights, filmmakers, and health-care educators. Genetics-based narratives are to be welcomed if the public is to understand genetic science and its implications on persons, families, and communities. However, a number of important ethical issues insist caution in their research and presentation. Just as the requirements for informed consent to undergo genetic testing exceed the requirements for informed consent to undergo other types of medical testing because of the inherent complex relationships (such as between parent and child, gene carrier and other family members, gene carrier and ethnic community) and because of concerns regarding privacy and insurance discrimination, the requirements for informed consent to present a genetics-based narrative must exceed the requirements for informed consent to present other medical narratives. We recommend that a transmedia, multidisciplinary, international conference should be convened to develop guidelines for the moral presentation of genetics-based narratives, whose deliberations should be informed by the protections provided for narrative research participants, the requirements of consent for genetic testing (which include a counseling process involving all appropriate family members), and a professional obligation to do no harm to the persons and families whose genetics-based stories we present.
Get full access to this article
View all access options for this article.
References
1.
Baylis, F.E. (1990) “The Ethics of ex utero Research on Spare ‘Non-viable’ IVF Human Embryos,”Bioethics4: 311-329 .
2.
Brunger, F. and Bassett, K. (1998) “Culture and Genetics,” in B.M. Knoppers (ed.) Socio-ethical Issues in Human Genetics, pp. 7-42. Cowansville, PQ: Les éditions Yvon Blais Inc.
3.
Bubela, T.M. and Caulfield, T.A. (2004) “Do the Print Media ‘Hype’ Genetic Research?,”Canadian Medical Association Journal170(9): 1399-1407 .
4.
Buchanan, A. , Brock, D.W. , Daniels, N. and Wikler, D. (2000) From Chance to Choice: Genetics and Justice. Cambridge: Cambridge University Press .
5.
Burgess, M.M. and d’Agincourt-Canning, L. (2001) “Genetic Testing for Hereditary Disease: Attending to Relational Responsibility,”J Clinical Ethics12(4): 361-372 .
6.
Burgess, M.M. , Laberge, C.M. and Knoppers, B.M. (1998) “Bioethics for Clinicians: 14. Ethics and Genetics in Medicine,”Canadian Medical Association Journal158(10): 1309-1313 .
7.
Burrell, D. and Hauerwas, S. (1977) “From System to Story: An Alternative Pattern for Rationality in Ethics,” in H.T.E. Callahan Jr. and D. Callahan (eds) The Foundation of Ethics and its Relationship to Science: Knowledge, Value and Belief, pp. 111-152. Hastings-on-Hudson, NY: Hastings Center .
8.
Caulfield, T. (2004) “Biotechnology and the Popular Press: Hype and the Selling of Science,”Trends in Biotechnology22(7): 337-339 .
9.
Cox, S.M. (2003) “Stories in Decisions: How At-risk Individuals Decide to Request Predictive Testing for Huntington Disease,”Qualitative Sociology26(2): 257-280 .
10.
Daar, A.S. and Mattei, J.-F. (1999) “Medical Genetics and Biotechnology: Implications for Public Health,” document WHO/EIP/GPE/00.1, Annex 1 of the Report of the Informal Consultation on Ethical Issues in Genetics, Cloning and Biotechnology: Possible Future Directions for WHO. Geneva: World Health Organization .
11.
Donald, A. (1998) “The Words We Live In,” in T. Greenhalgh and B. Hurwitz (eds) Narrative Based Medicine: Dialogue and Discourse in Clinical Practice, pp. 17-26. London: BMJ Books .
12.
Einsiedel, E.F. (2000) “Cloning and its Discontents—a Canadian Perspective,”Nature Biotechnology18(September): 943-944 .
13.
Einsiedel, E.F. and Medlock, J.E. (2001) “Canada on the Gene Trail,” in G. Gaskell and M. Bauer (eds) Biotechnology, 1996-2000: The Years of Controversy, pp. 145-156. London: NMSI Trading Ltd, Science Museum .
14.
Frazee, C. (2000) “Obscuring Disability: The Pursuit of ‘Quality’ in the CBS,” in F. Miller , L. Weir , R. Mykitiuk , P. Lee , S. Sherwin and S. Tudiver (eds) The Gender of Genetic Futures: The Canadian Biotechnology Strategy, Women and Health. Toronto: National Network on Environment and Women’s Health (NNEWH)Working Paper Series. URL: http://www.cwhn.ca/groups/biotech/availdocs/full-doc-2.pdf
15.
Frazee, C. , Gilmour. J. and Mykitiuk, R. (2005) “Now You See Her, Now You Don’t: How Law Shapes Disabled Women’s Experience of Exposure, Surveillance, and Assessment in the Clinical Encounter,” in D. Pothier and R. Dezlin (eds) Critical Disability Theory: Essays in Philosophy, Politics, Policy, and Law (in press). Vancouver: University of British Columbia Press .
16.
Garland, M. (1999) “Experts and the Public: A Needed Partnership for Genetic Policy,”Public Understanding of Science8: 241-245 .
17.
Genetics and the Law (2005) “Legal Cases: Genetic Discrimination—Life Insurance.” URL: http://www.genelaw.info/pages/caseresults.asp?area=6&status=0&submit2=GO
18.
Greenhalgh, T. and Hurwitz, B. (1998) “Why Study Narrative?,” in T. Greenhalgh and B. Hurwitz (eds) Narrative Based Medicine: Dialogue and Discourse in Clinical Practice, pp. 3-16. London: BMJ Books .
19.
Hacking, I. (1990) The Taming of Chance. Cambridge: Cambridge University Press .
20.
Howlett, M. and Ramesh, M. (1995) Studying Public Policy: Policy Cycles and Policy Subsystems. Toronto and New York: Oxford University Press .
21.
International Committee of Medical Journal Editors (ICMJE) (2004) Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. URL (updated October 2004): www.icmje.org
22.
Kanner, S. , Langerman, S. and Grey, M. (2004) “Ethical Considerations for a Child’s Participation in Research,”Journal for Specialists in Pediatric Nursing9(1): 15-23 .
23.
Kenny, N.P. (1994) “The Ethics of Care and the Patient-Physician Relationship,”Annals of the Royal College of Physicians and Surgeons of Canada17(6): 356-358 .
24.
Knoppers, B. and Joly, Y. (2004) “Physicians, Genetics and Life Insurance,”Canadian Medical Association Journal170(9): 1421-1423 .
25.
Knoppers, B.M. , Lemmens, T. , Godard, B. , Joly, Y. , Avard, D. , Clark, T. , Hamet, P. , Hoy, M. , Lanctôt, S. , Lowden, S. , Martin, H. , Maugard, C. , Millette, Y. , Simard, J. , Vachon, M.-H. and Zinatelli, F. (2004) “Canadian Genetics and Life Insurance Task Force. Genetics and Life Insurance in Canada: Points to Consider,”Canadian Medical Association Journal170(9): http://www.cmaj.ca/cgi/data/170/9/1421/DC2/1.
26.
Lemmens, T. and Bahamin, P. (1998) “Genetics in Life, Disability and Additional Health Insurance in Canada: A Comparative Legal and Ethical Analysis,” in B.M. Knoppers (ed.) Socio-ethical Issues in Human Genetics, pp. 104-275. Cowansville, PQ: Les éditions Yvon Blais Inc.
27.
Lippmann, A. (1993) “Worrying—and Worrying about—the Geneticization of Reproduction and Health,” in G. Basen , M. Eichler and A. Lippmann (eds) Misconceptions: The Social Construction of Choice and the New Reproductive and Genetic Technologies, vol. 1, pp. 39-65. Hull, QC: Voyageur Publishing .
28.
Montello, M. (1997) “Narrative Competence,” in H.L. Nelson (ed.) Stories and their Limits: Narrative Approaches to Bioethics, pp. 185-197. New York: Routledge .
29.
Nelson, H.L. (2001) Damaged Identities: Narrative Repair. New York: Cornell University Press .
30.
Newell, C. (1998) “The Ethics of Narrative Ethics: Some Teaching Reflections,”Health Care Analysis6: 171-174 .
31.
Nisker, J.A. (2001a) “Chalcedonies,”Canadian Medical Association Journal156(5): 689-691 .
32.
Nisker, J.A. (2001b) “Orchids: Not Necessarily a Gospel,” in J. Murray (ed.) Mappa Mundi: Mapping Culture/Mapping the World, pp. 61-109. Windsor, Ontario: University of Windsor Press .
33.
Nisker, J.A. (2003) “Philip,”Canadian Medical Association Journal168(6): 746-747 .
34.
Nisker, J.A. (2004a) “Ethical Issues of ‘Case’ Reports: What Can We Learn from Case Studies?,”Journal of Obstetrics and Gynaecology Canada26(1): 7-9 .
35.
Nisker, J.A. (2004b) “Narrative Ethics in Health Care,” in J. Storch , P. Rodney and R. Starzomski (eds) Toward a Moral Horizon, pp. 285-309. Toronto: Pearson Education Canada Inc.
36.
Parens, E. and Asch, A. (2000) “The Disability Rights Critique of Prenatal Genetic Testing: Reflections and Recommendations,” in E. Parens and A. Asch (eds) Prenatal Testing and Disability Rights, pp. 3-43. Washington, DC: Georgetown University Press :
37.
Priest, S.H. (1995) “Information Equity, Public Understanding of Science, and the Biotechnology Debate,”Journal of Communication45(1): 39-54 .
38.
Sherwin, S. (1994) “Feminism, Ethics, and Cancer,”Humane Medicine10(4): 282-290 .
39.
Sherwin, S. (1998) “A Relational Approach to Autonomy in Health Care,” in S. Sherwin (ed.) The Politics of Women’s Health, pp. 19-47. Philadelphia: Temple University Press .
40.
Smythe, W.E. and Murray, M.J. (2000) “Owning the Story: Ethical Considerations in Narrative Research,”Ethics and Behavior 210(4): 311-336 .
41.
Stake, R.E. (2000) “Case Studies,” in N.K. Denzin and Y.S. Lincoln (eds) Handbook of Qualitative Research, pp. 435-454. Thousand Oaks, CA: SAGE Publications .
42.
Taylor, K. and Mykitiuk, R. (2001) “Genetics, Normalcy and Disability,”ISUMA: Canadian Journal of Policy Research/Revue2(3): 65-71 .
43.
TCPS (2003) Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. Medical Research Council of Canada, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. June 2003. Ottawa: Public Works and Government Services Canada .
44.
Weijer, C. , Goldsand, G. and Emanuel, E.J. (1999) “Protecting Communities in Research: Current Guidelines and Limits of Extrapolation,”Nature Genetics23: 275-280 .
45.
Wertz, D. and Fletcher, J. (1991) “Privacy and Disclosure in Medical Genetics Examined in an Ethics of Care,”Bioethics5(3): 212-232 .
46.
Winston, J. (1999) “Theorising Drama as Moral Education,”Journal of Moral Education28(4): 459-471 .
